Germany Clinical Nutrition Market Size, Share, and COVID-19 Impact Analysis, By Product (Oral Clinical Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas), By Application (Alzheimer’s Disease, Nutrition Deficiency, Cancer care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, and Others), By Sales Channel (Retail Sales Channels, Online Sales Channels, and Institutional Sales Channels), and Germany Clinical Nutrition Market Insights, Industry Trend, Forecasts to 2033

Germany Clinical Nutrition Market Insights Forecasts to 2033

• The Germany Clinical Nutrition Market Size was valued at USD 1120.5 Million in 2023.
• The Germany Clinical Nutrition Market Size is Growing at a CAGR of 3.43% from 2023 to 2033
• The Germany Clinical Nutrition Market Size is Expected to exceed USD 1570.5 Million By 2033

The Germany Clinical Nutrition Market Size is Anticipated to exceed USD 1570.5 Million By 2033, Growing at a CAGR of 3.43% from 2023 to 2033. The increasing prevalence of chronic diseases, aging population, prevalence of malnutrition, and technological advancements are driving the clinical nutrition market in the Germany.     

Market Overview

Clinical nutrition market refers to the industry developing and selling food products in order to meet the nutritional demand with specific conditions. Clinical nutrition is a sub-discipline of human nutrition science and the practice of using nutrition to diagnose, treat, and prevent disease. Clinical nutrition aids in maintaining a healthy energy balance, while also providing sufficient amounts of nutrients such as protein, vitamins, and minerals to patients. There is an upsurging requirement for clinical dietary management along with the development of advanced clinical nutrition products with the growing prevalence of chronic diseases like Alzheimer’s disease, ADHD, osteoporosis, osteoarthritis, CNS disorders, and other chronic diseases. There is a rising trend for innovative formulations and personalized nutrition solutions along with the use of bioactive ingredients. The increase in a number of malnourished patients with malignancy, chronic disease, and/or anorexia contributes to offering lucrative market growth opportunities.

Report Coverage

This research report categorizes the market for the Germany clinical nutrition market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany clinical nutrition market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany clinical nutrition market.

Driving Factors

The increased prevalence of chronic diseases and metabolic disorders along with the aging population are responsible for propelling the clinical nutrition market demand as clinical nutrition aids in preventing the development of many chronic diseases. It was found that the prevalence of chronic diseases is high in the German elderly population, out of which hypertension is the most frequent chronic condition. The increasing awareness about the healthy lifestyle and the significance of nutrition on healthy lifestyle behavior are contributing to driving the market growth. Further, the integration of digital technologies and advancements in nutrition therapy aids in propelling the market growth. In addition, the prevalence of disease-associated malnutrition in Germany in children and adolescents is propelling the market.

Restraining Factors

The lack of awareness and limited reimbursement policies related to clinical nutrition products are challenging the market growth.

Market Segmentation

The Germany clinical nutrition market share is classified into product, application, and sales channel.

• The oral clinical nutrition segment dominated the market with the largest revenue share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

The Germany clinical nutrition market is segmented by product into oral clinical nutrition, parenteral nutrition, and enteral feeding formulas. Among these, the oral clinical nutrition segment dominated the market with the largest revenue share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. Vitamins, proteins, and carbohydrates in powder, liquid, and semi-solid forms are included in the oral clinical nutrition segment. The prevalence of malnutrition and the introduction of new flavors into the product are driving the market.

• The cancer care segment is dominating the market with the largest revenue share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe.

Based on the application, the Germany clinical nutrition market is divided into Alzheimer’s disease, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, and others. Among these, the cancer care segment is dominating the market with the largest revenue share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe. Maintaining good nutrition is essential for cancer patients to tolerate the side effects of treatment as it aids in maintaining patient strength. The increased burden of cancer and the use of various types of clinical nutrition like tube feeding are propelling the market.

• The institutional sales channels segment is dominating the market with the largest market share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe.

Based on the sales channel, the Germany clinical nutrition market is divided into retail sales channels, online sales channels, and institutional sales channels. Among these, the institutional sales channels segment is dominating the market with the largest market share in 2023 and is expected to grow at a significant CAGR growth during the projected timeframe. In institutional sales, nutritional products are sold directly to healthcare institutions including hospitals, nursing homes, long-term care facilities, and hospices. The rising number of private and public institutions along with the prevalence of chronic diseases contributes to driving the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany clinical nutrition market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Hipp International
• Norgine
• Toepfer GmbH
• Dr Schar
• Fresenius Kabi
• B. Braun Melsungen
• Abbott Nutrition
• Danone Nutricia
• Bayer AG
• Nestle
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Germany Clinical Nutrition Market based on the below-mentioned segments

Germany Clinical Nutrition Market, By Product

• Oral Clinical Nutrition
• Parenteral Nutrition
• Enteral Feeding Formulas

Germany Clinical Nutrition Market, By Application    

• Alzheimer’s Disease
• Nutrition Deficiency
• Cancer care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Others

Germany Clinical Nutrition Market, By Sales Channel

• Retail Sales Channels
• Online Sales Channels
• Institutional Sales Channels